US EditionFor Dementia Patients, Easy Access to Experts May Help the Most
UCSF study shows collaborative dementia care saves $48,000 per patient and extends home stay by four months compared to costly Alzheimer’s drug lecanemab.
5 Articles
5 Articles
The care, care and therapy of people with dementia are major challenges. A study now shows how important a good support could be.
For dementia patients, easy access to experts may help the most
A Medicare-covered program that offers support and medical advice for caregivers of patients with dementia may bring more benefit than a costly Alzheimer's medication, research finds. UC San Francisco researchers have compared outcomes for patients in collaborative care programs with those taking lecanemab, one of two approved drugs that have been shown to slow progression of Alzheimer's in some patients.
Programs that support caregivers of dementia patients could bring substantial benefits to a fraction of the price of a drug against Alzheimer's disease. A computer simulation guided by data from patients from previous studies revealed that support care reduces the costs of health care and obtains [...]
Easy Access to Experts Could Significantly Benefit Dementia Patients, Study
In the evolving landscape of dementia care, a new study from the University of California, San Francisco (UCSF) reveals that collaborative care programs may outperform one of the most promising Alzheimer’s drugs to date—lecanemab. While lecanemab has shown potential in slowing the progression of Alzheimer’s disease in clinical trials, UCSF researchers now provide compelling evidence that programs offering easy access to expert patient navigators…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
